{"filing":{"accession_number":"0001213900-26-098588","cik":"0001676163","ticker":"SSII","company_name":"SS Innovations International, Inc.","form":"8-K","filing_date":"2026-09-10","report_date":"2026-09-10","primary_document":"ea0305024-8k_ssinnova.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1676163/000121390026098588/ea0305024-8k_ssinnova.htm"},"events":[{"id":32563,"run_id":29921,"accession_number":"0001213900-26-098588","anchor_item_number":"8.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"The press release discloses operational and commercial milestones for SS Innovations' SSi Mantra surgical robotic system, including global expansion into Colombia and Sri Lanka, pediatric surgery achievements (258 cumulative procedures), telesurgery records (188 cumulative telesurgeries), and significant growth metrics (238 installed systems up 42% YoY, 14,103 procedures up 79% YoY). While these are business progress updates rather than a discrete event like M\u0026A or a material impairment, the scale of growth, geographic expansion, and regulatory progress (FDA 510(k) expected Q1 2027, EU CE marking expected end of 2026) would materially affect a reasonable investor's assessment of the company's commercial trajectory and market penetration.","company_name":"SS Innovations International, Inc.","ticker":"SSII","filing_date":"2026-09-10","form":"8-K","submitted_at":null,"items":[{"id":35762,"accession_number":"0001213900-26-098588","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The press release discloses operational and commercial milestones for SS Innovations' SSi Mantra surgical robotic system, including global expansion into Colombia and Sri Lanka, pediatric surgery achievements (258 cumulative procedures), telesurgery records (188 cumulative telesurgeries), and significant growth metrics (238 installed systems up 42% YoY, 14,103 procedures up 79% YoY). While these are business progress updates rather than a discrete event like M\u0026A or a material impairment, the scale of growth, geographic expansion, and regulatory progress (FDA 510(k) expected Q1 2027, EU CE marking expected end of 2026) would materially affect a reasonable investor's assessment of the company's commercial trajectory and market penetration.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T12:31:51.760062+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35762,"accession_number":"0001213900-26-098588","item_number":"8.01","item_title":"Other Events.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"The press release discloses operational and commercial milestones for SS Innovations' SSi Mantra surgical robotic system, including global expansion into Colombia and Sri Lanka, pediatric surgery achievements (258 cumulative procedures), telesurgery records (188 cumulative telesurgeries), and significant growth metrics (238 installed systems up 42% YoY, 14,103 procedures up 79% YoY). While these are business progress updates rather than a discrete event like M\u0026A or a material impairment, the scale of growth, geographic expansion, and regulatory progress (FDA 510(k) expected Q1 2027, EU CE marking expected end of 2026) would materially affect a reasonable investor's assessment of the company's commercial trajectory and market penetration.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-10T12:31:51.760062+00:00","company_name":"SS Innovations International, Inc.","ticker":"SSII","filing_date":"2026-09-10"}]}